OCC
Asset Logo

Orthocell Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

4
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. The company is headquartered in Perth, Western Australia. The company went IPO on 2014-08-12. The firm is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes CelGro, Striate+, Remplir, and SmrtGraft. CelGro is a collagen medical device that facilitates tissue reconstruction and healing in a variety of dental and orthopedic reconstructive applications. CelGro is manufactured using a SMRT manufacturing process to preserve the natural collagen structure. Striate+ is used for dental GBR applications. Remplir is for peripheral nerve reconstruction. SmrtGraft is for tendon repair. Its other major products are autologous cell therapy, which focuses on regenerating damaged tendon and cartilage tissue. The company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.

📈 Performance

Price History

-7.50%

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.37

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in OCC

4

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in OCC

488 days
OCC investor breakdown
💵 Income of investors

More than 200k

150k - 200k

25%

100k - 150k

50k - 100k

50%

Less than 50k

25%
👶 Age of investors

18 - 25

25%

26 - 34

50%

35 - 90

25%
🙋 Legal gender of investors

Female

50%

Male

50%

Pearlers who invest in OCC also invest in...

Vanguard Australian Shares Index Etf

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

📊 Share price

$90.18 AUD

NULL AUSTRALIA

NULL BETA

Find Out More

VDHG

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

📊 Share price

$57.36 AUD

NULL GLOBAL

NULL SMART BETA

Qantas Airways Ltd. provides air transportation services. The company is headquartered in Mascot, New South Wales. The firm is focused on the operation of international and domestic air transportation services, the provision of freight services, and the operation of a frequent flyer loyalty program. The firm's segments include Qantas Domestic, Qantas International, Jetstar Group and Qantas Loyalty. The Qantas Domestic, Qantas International, and Jetstar Group are engaged in passenger flying business and air cargo and express freight businesses. The Qantas Loyalty segment is engaged in the customer loyalty recognition programs. Its main business is the transportation of customers using two airline brands, which include Qantas and Jetstar. Its airline brands operate in regional, domestic and international services. The firm operates in Australia, New Zealand, South Pacific, Asia, Europe, North and South America, and Africa.

📊 Share price

$6.51 AUD

NULL AIRLINES

VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

📊 Share price

$320.13 AUD

NULL US

NULL EX AUSTRALIA

NULL BETA

Medlab Clinical Ltd. engages in the development of therapeutic pathways for diagnosed chronic diseases. The company is headquartered in Alexandria, New South Wales. The company went IPO on 2015-07-14. The firm is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The firm's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The firm also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.

📊 Share price

$6.60 AUD

Want more shares? Try these...

Objective Corp. Ltd. engages in the supply of information technology software and services. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2000-08-17. The Company’s Objective Content Solutions products enable customers to manage information and process governance across the enterprise. The company also enables customers to collaborate with external organizations with the security, information governance and auditability demanded by the government. Its Objective Keystone products improve efficiency and deliver government in the process of authoring, reviewing, engaging with and publishing documents. Its Objective RegWorks and Objective Reach products are focused on the delivery of government regulation technology solutions. Its Objective Planning Solutions include Objective Trapeze products, which digitally transform development application plan reviews and assessments, and Objective Alpha and Master Business Systems, which provide end-to-end building consenting solutions.

📊 Share price

$13.83 AUD

Oceana Lithium Ltd. operates as a mineral exploration and development company. The company is headquartered in Perth, Western Australia. The company went IPO on 2022-07-01. The firm is focused on the discovery and delineation of lithium mineral resources in two mining-friendly jurisdictions, the state of Ceara, Brazil, and the Northern Territory, Australia. The firm's projects include Solonopole Lithium Project and the Napperby Lithium project. The Solonopole lithium project, located in Ceara State, northeastern Brazil, consists of approximately eight mining permits covering approximately 114 square kilometers (Km2). The Napperby lithium project consists of a granted exploration license (EL32836) covering an area of approximately 650km2 and an exploration license application (ELA32841) covering an area of more than 512km2. The Napperby lithium project is located within the Northern Arunta pegmatite province near the settlement of Ti Tree, approximately 250km northwest of Alice Springs and 250km south of Tennant Creek.

📊 Share price

$0.30 AUD

Ora Banda Mining Ltd. engages in the development and exploration of gold. The company is headquartered in Perth, Western Australia. The company went IPO on 2002-10-29. The firm is engaged in mineral exploration, mine development and operation and the sale of gold in Western Australia. Its projects include Davyhurst, Riverina-Mulline, Siberia, Callion, Walhalla, and Lady Idaa. The Davyhurst Gold Project is located approximately 120 kilometers north-west of Kalgoorlie, within the tier one gold mining province of the Eastern Goldfields in Western Australia. The Company’s tenement package consists of approximately 92 granted tenements covering an area of approximately 1,200 square kilometers (km2). The company offers a coverage of approximately 130 strike kilometers of greenstone sequences prospective for gold as well as nickel sulfide and base metal mineralization. The Riverina-Mulline Project area is approximately 44 drive-km north of the Davyhurst processing plant. The Callion Project area is located approximately 13 km south-west of the Davyhurst processing plant.

📊 Share price

$0.14 AUD

Oceania Healthcare Ltd. engages in the provision of health care solution. The firm operates through three segments. The care segment is engaged in providing products, such as traditional care beds and care suites. The segment is involved in the provision of accommodation, care and related services to the Company’s aged care residents; and services, such as meals and care packages to independent living residents. The village operations segment is engaged in providing products, such as independent living and rental properties. The segment is involved in the provision of accommodation and related services to independent residents in the Company’s retirement villages. The other segment is involved in the provision of support services to the Company, which includes administration, marketing and operations. In addition, this segment includes the provision of training by the Wesley Institute of Learning.

📊 Share price

$0.74 AUD
Compare
Add to watchlist